Impact of high-dose atorvastatin therapy and clinical risk factors on incident aortic valve stenosis in patients with cardiovascular disease (from TNT, IDEAL, and SPARCL).

[1]  Kathleen F. Kerr,et al.  Genetic associations with valvular calcification and aortic stenosis. , 2013, The New England journal of medicine.

[2]  Zhejun Cai,et al.  Pioglitazone attenuates progression of aortic valve calcification via down-regulating receptor for advanced glycation end products , 2012, Basic Research in Cardiology.

[3]  P. Pibarot,et al.  Inhibition of ectonucleotidase with ARL67156 prevents the development of calcific aortic valve disease in warfarin-treated rats. , 2012, European journal of pharmacology.

[4]  K. J. Grande-Allen,et al.  Calcific Aortic Valve Disease : Not Simply a Degenerative Process A Review and Agenda for Research from the National Heart and Lung and Blood Institute Aortic Stenosis Working Group , 2012 .

[5]  J. Després,et al.  Hypoadiponectinemia Is Associated with Valvular Inflammation and Faster Disease Progression in Patients with Aortic Stenosis , 2011, Cardiology.

[6]  W. Aronow,et al.  Association of Warfarin Use With Valvular and Vascular Calcification: A Review , 2011, Clinical cardiology.

[7]  J. Després,et al.  Metabolic syndrome is associated with more pronounced impairment of left ventricle geometry and function in patients with calcific aortic stenosis: a substudy of the ASTRONOMER (Aortic Stenosis Progression Observation Measuring Effects of Rosuvastatin). , 2010, Journal of the American College of Cardiology.

[8]  K. Teo,et al.  Effect of Lipid Lowering With Rosuvastatin on Progression of Aortic Stenosis: Results of the Aortic Stenosis Progression Observation: Measuring Effects of Rosuvastatin (ASTRONOMER) Trial , 2010, Circulation.

[9]  W. Aronow,et al.  Warfarin use and the risk of valvular calcification , 2009, Journal of thrombosis and haemostasis : JTH.

[10]  A. Mahnken,et al.  Relation of circulating matrix Gla-protein and anticoagulation status in patients with aortic valve calcification , 2009, Thrombosis and Haemostasis.

[11]  K. Masters,et al.  Efficacy of Simvastatin Treatment of Valvular Interstitial Cells Varies With the Extracellular Environment , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[12]  M. Budoff,et al.  Relationship of Metabolic Syndrome With Incident Aortic Valve Calcium and Aortic Valve Calcium Progression , 2009, Diabetes.

[13]  J. Chambers,et al.  Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. , 2008, The New England journal of medicine.

[14]  J. Zamorano,et al.  Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis. , 2007, Journal of the American College of Cardiology.

[15]  J. Farmer.  High-dose atorvastatin after stroke or transient ischemic attack. , 2007, Current atherosclerosis reports.

[16]  O. Faergeman,et al.  High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial. , 2005, JAMA.

[17]  R. Prescott,et al.  A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. , 2005, The New England journal of medicine.

[18]  F. Dagenais,et al.  Calcification of human valve interstitial cells is dependent on alkaline phosphatase activity. , 2005, The Journal of heart valve disease.

[19]  Philip J. Barter,et al.  Intensive lipid lowering with atorvastatin in patients with stable coronary disease. , 2005, The New England journal of medicine.

[20]  E. Mohler,et al.  Paradoxical Effects of Statins on Aortic Valve Myofibroblasts and Osteoblasts: Implications for End-Stage Valvular Heart Disease , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[21]  R. Bonow,et al.  Atorvastatin Inhibits Hypercholesterolemia-Induced Cellular Proliferation and Bone Matrix Production in the Rabbit Aortic Valve , 2002, Circulation.

[22]  Catherine M. Otto,et al.  Clinical Factors Associated With Calcific Aortic Valve Disease , 1997 .

[23]  Bonnie K. Lind,et al.  Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. , 1997, Journal of the American College of Cardiology.

[24]  W. Edwards,et al.  Temporal changes in the causes of aortic stenosis: a surgical pathologic study of 646 cases. , 1987, Mayo Clinic proceedings.